Vimarsana
Biggest News Aggregation in the World

Page 3 - Pfizer Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pfizer Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pfizer Inc Today - Breaking & Trending Today

Coastwise Capital Group LLC Acquires 1,930 Shares of Pfizer Inc. (NYSE:PFE) - Vimarsana News

Coastwise Capital Group LLC Acquires 1,930 Shares of Pfizer Inc. (NYSE:PFE)

Coastwise Capital Group LLC raised its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 5.8% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 35,467 shares of the biopharmaceutical company’s stock after buying an additional 1,930 shares during the period. Pfizer accounts for about 1.0% of Coastwise Capital Group LLC’s investment […]

Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with Duchenne Muscular Dystrophy - Vimarsana News

Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with Duchenne Muscular Dystrophy

Pfizer Inc. today announced that CIFFREO, a Phase 3 global, multicenter, randomized, double-blind, placebo-controlled study evaluating the investigational mini-dystrophin gene therapy,...

Connect Biopharma : INFORMATION CONTAINED IN THIS REPORT ON FORM 6 K Form 6 K - Vimarsana News

Connect Biopharma : INFORMATION CONTAINED IN THIS REPORT ON FORM 6 K Form 6 K

Document UNITED STATES SECURITIES...

How Moderna Makes Money: Product Sales, Grant Revenue, and Collaboration Revenue - Vimarsana News

How Moderna Makes Money: Product Sales, Grant Revenue, and Collaboration Revenue

Moderna's makes money through the sale of biotech products, plus some grant and collaboration revenue. Its COVID-19 vaccine continues to drive revenues.

Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with Duchenne Muscular Dystrophy - Vimarsana News

Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with Duchenne Muscular Dystrophy

NEW YORK--(BUSINESS WIRE)--Jun 12, 2024--